TRVI Competitors & Alternatives
Compare Trevi Therapeutics Inc with similar stocks in the same industry
Biotechnology
TRVI
Main Stock$13.90
Tradestie Score
54
Market Cap
$1.14B
Analyst Upside
+57.6%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$39.95
|
$2.21B | - | 61 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$18.38
|
$2.18B | - | 48 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$15.54
|
$2.08B | - | 56 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$20.63
|
$2.02B | - | 56 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$11.93
|
$2.01B | - | 48 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$35.40
|
$1.97B | - | 58 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.09
|
$1.92B | - | 63 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$117.91
|
$1.92B | - | 59 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$37.86
|
$1.90B | - | 58 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$35.83
|
$1.84B | - | 48 | Compare |
More TRVI Analysis
Data updated: Apr 29, 2026 | Industry: Biotechnology (SIC 2834)
226 stocks in this industry